Apellis Pharmaceuticals, Inc. (APLS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:03AM EDT. Market open.
| Previous close | 47.49 |
| Open | 48.46 |
| Bid | 44.35 x 200 |
| Ask | 51.51 x 200 |
| Day's range | 47.31 - 48.76 |
| 52-week range | 19.83 - 94.75 |
| Volume | |
| Avg. volume | 1,421,929 |
| Market cap | 5.74B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
Syros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
Apellis Pharmaceuticals (APLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.